Pharmaceutics | |
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives | |
Yingying Xu1  Pak-Wai Yuen1  | |
[1]Department of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, 21 Sassoon Road, Hong Kong, China | |
关键词: DNA vaccine; intranasal delivery; infectious diseases; respiratory pathogens; adjuvants; mucosal; | |
DOI : 10.3390/pharmaceutics6030378 | |
来源: mdpi | |
【 摘 要 】
Intranasal delivery of DNA vaccines has become a popular research area recently. It offers some distinguished advantages over parenteral and other routes of vaccine administration. Nasal mucosa as site of vaccine administration can stimulate respiratory mucosal immunity by interacting with the nasopharyngeal-associated lymphoid tissues (NALT). Different kinds of DNA vaccines are investigated to provide protection against respiratory infectious diseases including tuberculosis, coronavirus, influenza and respiratory syncytial virus (RSV)
【 授权许可】
CC BY
© 2014 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190024067ZK.pdf | 1637KB | download |